Merit Medical Systems Selected As a Founding Member of New NASDAQ Health Care Index
Merit Medical Systems Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable accessories used primarily in cardiology and radiology procedures, announced that it has been selected as a founding member of the new NASDAQ Health Care Index (Symbol: IXHC) and that its common shares have been added to it.
The NASDAQ Health Care Index is a market value weighted index that contains 542 NASDAQ-listed companies which are classified by the FTSE Global Classification System as “Health,”"Pharmaceutical” or “Biotechnology.” They include health maintenance organizations, hospital management and long-term care, medical equipment and supplies, other health care, biotechnology and pharmaceutical companies.
“We are pleased about the additional exposure investors will have to Merit Medical and our growing sector through this new index,” said Fred P. Lampropoulos, chairman and CEO of Merit Medical.
About Merit
Founded in 1987, Merit Medical Systems Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical accessories used in interventional and diagnostic procedures, particularly in cardiology and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 80 individuals. Merit employs approximately 1,440 people worldwide, with manufacturing facilities in Salt Lake City and South Jordan, Utah; Santa Clara, Calif.; Angleton, Texas; Richmond, Va.; Maastricht, Netherlands; and Galway, Ireland.
Statements contained in this release which are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 and are subject to risks and uncertainties such as those described in Merit’s Annual Report on Form 10-K for the year ended Dec. 31, 2004. Such risks and uncertainties include market acceptance of new products, introduction of products in a timely fashion, product recalls, delays in obtaining regulatory approvals, or the failure to maintain such approvals, cost increases, fluctuations in and obsolescence of inventory, price and product competition, availability of labor and materials, development of new products and technology that could render our products obsolete, product liability claims, modification or limitation of governmental or private insurance reimbursement, infringement of our technology or the assertion that our technology infringes the rights of other parties, foreign currency fluctuations, challenges associated with the company’s growth strategy, changes in health care markets related to health care reform initiatives, litigation and other factors referred to in the company’s 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.